Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
PACB Pacific Biosciences of California
- 1.960
- -0.085-4.16%
Close Dec 13 16:00 ET
- 1.960
- 0.0000.00%
Post 19:59 ET
576.86MMarket Cap-1.34P/E (TTM)
2.080High1.880Low10.59MVolume2.080Open2.045Pre Close20.50MTurnover3.84%Turnover RatioLossP/E (Static)294.32MShares10.65052wk High1.27P/B541.39MFloat Cap1.16052wk Low--Dividend TTM276.22MShs Float53.690Historical High--Div YieldTTM9.78%Amplitude1.060Historical Low1.935Avg Price1Lot Size
Pacific Biosciences of California Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 30.25%-45.46M | -30.00%-54.26M | 20.07%-75.68M | 1.53%-259.17M | 4.96%-57.56M | -3.37%-65.18M | 31.08%-41.74M | -19.82%-94.69M | -136.74%-263.21M | -91.01%-60.57M |
| Net income from continuing operations | 9.19%-60.73M | -148.19%-173.32M | 11.18%-78.18M | 2.39%-306.74M | 2.80%-82.02M | 13.12%-66.87M | 2.19%-69.83M | -8.00%-88.02M | -73.40%-314.25M | -21.72%-84.38M |
| Operating gains losses | ---- | ---- | ---- | --2.03M | --0 | --0 | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 195.12%16.1M | 193.77%14.29M | 166.03%12.01M | 53.22%26.53M | 157.46%11.7M | 26.42%5.46M | 13.99%4.86M | 7.73%4.52M | 49.49%17.32M | 11.24%4.54M |
| Deferred tax | ---- | ---- | ---- | ---11.42M | ---718K | ---- | ---- | ---- | --0 | --0 |
| Other non cash items | -57.04%1.47M | -84.91%299K | -97.36%333K | 492.23%19.51M | -69.88%1.49M | -24.34%3.42M | 137.53%1.98M | 1,495.91%12.62M | -93.87%3.3M | 265.61%4.95M |
| Change In working capital | -37.10%-17.27M | -240.43%-6.33M | 41.23%-25.35M | -9.24%-58.96M | -36.22%-7.74M | 13.63%-12.6M | 150.40%4.51M | -74.15%-43.13M | -365.52%-53.97M | -154.19%-5.68M |
| -Change in receivables | 147.27%3.05M | -137.98%-2.11M | 158.24%6.29M | -426.84%-17.83M | -254.38%-6.13M | -249.98%-6.45M | 599.62%5.56M | -199.17%-10.8M | 176.12%5.46M | 1,445.76%3.97M |
| -Change in inventory | 143.64%1.37M | 19.92%-5.11M | 12.49%-11.66M | 59.18%-13.84M | 185.47%9.01M | 62.60%-3.15M | 23.03%-6.38M | -99.95%-13.32M | -158.65%-33.91M | -37.66%-10.54M |
| -Change in prepaid assets | 97.92%-25K | -36.74%508K | 144.29%3.05M | 27.10%-8.98M | 74.44%-1.7M | 77.51%-1.2M | -4.97%803K | -481.27%-6.89M | -1,103.52%-12.32M | -548.97%-6.64M |
| -Change in payables and accrued expense | -265.48%-9.03M | -142.82%-2.75M | -110.75%-17.11M | 606.82%13.31M | 38.04%9.55M | 1,029.40%5.46M | 669.34%6.42M | 25.26%-8.12M | -112.11%-2.63M | -38.35%6.92M |
| -Change in other current liabilities | -122.72%-10.47M | 99.18%1.69M | -70.16%-7.53M | -209.96%-21.19M | -1,781.90%-12.92M | -13.23%-4.7M | -9.87%849K | -0.64%-4.42M | -18.02%-6.84M | 76.96%768K |
| -Change in other working capital | 14.86%-2.17M | 152.74%1.45M | 278.49%1.6M | -179.06%-10.42M | -3,392.45%-5.55M | -74.66%-2.55M | 32.58%-2.74M | -78.30%423K | -114.51%-3.73M | -102.04%-159K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 30.25%-45.46M | -30.00%-54.26M | 20.07%-75.68M | 1.53%-259.17M | 4.96%-57.56M | -3.37%-65.18M | 31.08%-41.74M | -19.82%-94.69M | -136.74%-263.21M | -91.01%-60.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -90.48%23.07M | 177.94%76.84M | 52.95%-34.14M | -96.03%4.6M | -182.80%-66.58M | 349.51%242.32M | -63.55%-98.59M | -272.53%-72.55M | 117.11%116.08M | 22.28%80.4M |
| Net PPE purchase and sale | 194.82%787K | 34.79%-1.48M | -4.25%-3.88M | 47.21%-8.84M | 58.73%-2.02M | 80.19%-830K | 43.57%-2.27M | -2.28%-3.72M | -182.41%-16.75M | -72.55%-4.9M |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---179K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---102K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | -90.84%22.28M | 181.31%78.32M | 56.04%-30.26M | -89.81%13.55M | -175.51%-64.55M | 318.70%243.26M | -71.20%-96.32M | -250.65%-68.83M | 137.70%133.01M | 24.62%85.49M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -90.48%23.07M | 177.94%76.84M | 52.95%-34.14M | -96.03%4.6M | -182.80%-66.58M | 349.51%242.32M | -63.55%-98.59M | -272.53%-72.55M | 117.11%116.08M | 22.28%80.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 203.97%812K | 96.78%-152K | -96.66%6.55M | 1,031.69%108.89M | -10,063.61%-81.6M | -124.93%-781K | -1,136.26%-4.72M | 3,658.18%195.99M | -99.18%9.62M | -38.14%819K |
| Net issuance payments of debt | --0 | 67.31%-152K | 24.22%-338K | -14.55%-1.84M | -3.97%-445K | -18.54%-486K | -18.32%-465K | -18.30%-446K | -100.18%-1.61M | -18.56%-428K |
| Net common stock issuance | --0 | --0 | --0 | --189.2M | --0 | --0 | --0 | --189.2M | --0 | --0 |
| Proceeds from stock option exercised by employees | -82.20%812K | --0 | -4.75%6.89M | 36.41%15.32M | -24.94%936K | 28.76%4.56M | 204.95%2.59M | 29.38%7.24M | -64.69%11.23M | -25.99%1.25M |
| Net other financing activities | ---- | ---- | ---- | ---93.79M | ---82.09M | ---4.86M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 203.97%812K | 96.78%-152K | -96.66%6.55M | 1,031.69%108.89M | -10,063.61%-81.6M | -124.93%-781K | -1,136.26%-4.72M | 3,658.18%195.99M | -99.18%9.62M | -38.14%819K |
| Net cash flow | ||||||||||
| Beginning cash position | -51.99%101.79M | -78.34%76.65M | -44.37%182.63M | -29.52%328.31M | 26.24%388.37M | -32.41%212.01M | -17.44%353.83M | -29.52%328.31M | 441.98%465.82M | -28.53%307.66M |
| Current changes in cash | -112.24%-21.59M | 115.46%22.42M | -459.25%-103.27M | -5.94%-145.68M | -1,096.02%-205.74M | 3,033.48%176.36M | -20.48%-145.05M | 190.50%28.75M | -136.20%-137.51M | -41.60%20.66M |
| End cash Position | -79.35%80.2M | -51.99%101.79M | -78.34%76.65M | -44.66%179.91M | -44.66%179.91M | 26.24%388.37M | -32.41%212.01M | -17.44%353.83M | -29.44%325.09M | -29.44%325.09M |
| Free cash flow | 32.32%-44.68M | -26.66%-55.74M | 19.16%-79.56M | 4.33%-268.02M | 9.24%-59.58M | 1.83%-66.01M | 31.86%-44.01M | -19.05%-98.41M | -139.21%-280.14M | -90.01%-65.65M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.